Axogen
(NASDAQ) AXGN
Axogen Financials at a Glance
Market Cap
$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$238.11M
Net Income (TTM)
-$31.45M
EPS (TTM)
-$0.63
P/E Ratio
-64.07
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$40.58
Volume
2,139,742.483
Open
$43.42
Price
$40.58
Volume
2,139,742.483
Open
$43.42
Previous Close
$40.58
Daily Range
$39.55 - $43.65
52-Week Range
$11.25 - $46.95
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$40.58
Volume
2,139,742.483
Open
$43.42
Previous Close
$40.58
Daily Range
$39.55 - $43.65
52-Week Range
$11.25 - $46.95
Estimated Earnings Date
Aug 4, 2026
AXGN News
AXGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Axogen
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
622
CEO
Michael D. Dale
Website
www.axogeninc.comHeadquarters
Alachua, FL 32615, US
AXGN Financials
Key Financial Metrics (TTM)
Gross Margin
75.01%
Operating Margin
-3.79%
Net Income Margin
-13.21%
Return on Equity
-20.74%
Return on Capital
-3.99%
Return on Assets
-10.87%
Earnings Yield
-1.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
53.18M
Volume
2.14M
Avg. Volume
1.25M
Financials (TTM)
Gross Profit
$178.61M
Operating Income
-$9.02M
EBITDA
-$8.24M
Operating Cash Flow
$15.56M
Capital Expenditure
-$6.62M
Free Cash Flow
$8.93M
Cash & ST Invst.
$82.65M
Total Debt
$20.64M
Axogen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$61.46M
+26.6%
Gross Profit
$46.19M
+32.2%
Gross Margin
75.16%
N/A
Market Cap
$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.47M
N/A
Employees
622
N/A
Net Income
-$19.58M
-410.8%
EBITDA
-$16.77M
-5725.8%
Quarterly Fundamentals
Total Cash
$82.65M
+274.5%
Total Debt
$20.64M
-69.8%
Accounts Receivable
$28.31M
+7.7%
Inventory
$46.07M
+29.8%
Long Term Debt
$18.53M
-72.1%
Short Term Debt
$2.12M
+1.3%
Return on Assets
-10.87%
N/A
Return on Invested Capital
-3.42%
N/A
Free Cash Flow
-$1.22M
+90.9%
Operating Cash Flow
$1.57M
+111.9%